BioXcel Therapeutics' net worth, reflected via its total market capitalization, fluctuates dynamically based on daily share price movements on the NASDAQ exchange. As a clinical-stage biopharmaceutical enterprise navigating high research and development expenditures alongside variable micro-cap valuations, its market capitalization sits in the lower-tier small-cap biotech bracket.